Department of Vascular Surgery, Heart & Vascular Institute, Cleveland Clinic, Cleveland, Ohio.
Department of Vascular Surgery, Heart & Vascular Institute, Cleveland Clinic, Cleveland, Ohio.
J Vasc Surg. 2021 Mar;73(3):819-825. doi: 10.1016/j.jvs.2020.06.122. Epub 2020 Jul 21.
The ideal mating stent for target vessel revascularization in fenestrated endovascular aneurysm repair (FEVAR) of juxtarenal and thoracoabdominal aortic aneurysms remains unknown. The objective of this study was to assess the outcomes associated with use of different stent types and configurations mated with reinforced fenestrations during FEVAR.
Clinical data from patients undergoing FEVAR for juxtarenal and thoracoabdominal aortic aneurysms in a prospective physician-sponsored investigational device exemption trial were analyzed. Outcomes for two different balloon-expandable covered stents (BECSs) mated with reinforced fenestrations were assessed along with the impact of distal extension with a self-expanding stent (SES). Primary patency, branch-related endoleak, and reintervention rates were determined. Cox proportional hazards model was used for time-to-event analysis.
From 2001 to 2016, there were 918 patients who underwent fenestrated or branched endograft repair of complex aortic aneurysms; 1604 renal arteries (RAs), 714 superior mesenteric arteries (SMAs), and 333 celiac arteries (CAs) were mated with reinforced fenestrations using JOMED (n = 2014; Abbott Vascular, Santa Clara, Calif) or iCAST (n = 637; Atrium Medical, Hudson, NH) BECSs. The type of BECS did not affect short-term or long-term patency, branch-related endoleaks, or reintervention rates in the RA, SMA, or CA. Twenty-five percent (402/1604) of RAs, 84% (598/714) of SMAs, and 8% (27/333) of CAs underwent distal SES extension at the index operation. RAs with a distal SES in addition to the BECS had a higher likelihood of an occlusion event (hazard ratio, 2.791; 95% confidence interval, 1.42-5.48; P = .003) and reinterventions (P = .036) compared with those without an SES. Addition of a distal SES to the BECS in the SMA or CA did not have an impact on patency or reintervention rates.
BECS choice does not appear to have an impact on branch durability after FEVAR. Selective distal SES placement in RAs with high-risk anatomy does not appear to significantly protect against an occlusion event or to prevent secondary interventions. Routine addition of a distal SES does not improve SMA fenestration durability.
在肾周和胸腹主动脉瘤的腔内血管重建中,用于开窗的理想交配支架仍不清楚。本研究的目的是评估在腔内血管重建中使用不同类型和配置的支架与增强的开窗匹配时的相关结果。
对前瞻性医生发起的研究性器械豁免试验中接受肾周和胸腹主动脉瘤腔内血管重建的患者的临床数据进行分析。评估了两种不同的球囊扩张覆膜支架(BECS)与增强开窗的匹配情况,并评估了自膨式支架(SES)远端扩展的影响。确定了原发性通畅率、分支相关内漏和再干预率。使用 Cox 比例风险模型进行时间相关分析。
2001 年至 2016 年,有 918 例患者接受了复杂主动脉瘤的开窗或分支血管内修复;1604 个肾动脉(RA)、714 个肠系膜上动脉(SMA)和 333 个腹腔动脉(CA)通过增强的开窗与 JOMED(n=2014;雅培血管,圣克拉拉,加利福尼亚州)或 iCAST(n=637;Atrium Medical,哈德逊,新罕布什尔州)BECS 进行了匹配。BECS 的类型并不影响 RA、SMA 或 CA 的短期或长期通畅率、分支相关内漏或再干预率。25%(402/1604)的 RA、84%(598/714)的 SMA 和 8%(27/333)的 CA 在指数手术中进行了远端 SES 扩展。在 BECS 之外增加远端 SES 的 RA 更有可能发生闭塞事件(风险比,2.791;95%置信区间,1.42-5.48;P=0.003)和再次干预(P=0.036),而没有 SES 的 RA 则没有。在 SMA 或 CA 中,将远端 SES 添加到 BECS 并不会对通畅率或再干预率产生影响。
BECS 的选择似乎对 FEVAR 后的分支耐久性没有影响。在具有高风险解剖结构的 RA 中选择性地放置远端 SES 并不能显著防止闭塞事件或防止二次干预。常规添加远端 SES 并不能提高 SMA 开窗的耐久性。